E. Fahy, A comprehensive classification system for lipids, J. Lipid Res, vol.46, pp.839-61, 2005.
DOI : 10.1201/b10501-31

URL : https://dspace.library.uu.nl/bitstream/1874/7962/2/3.Fahy2005%20pp839-861.pdf

A. A. Momin, A method for visualization of "omic" datasets for sphingolipid metabolism to predict potentially interesting differences, J. Lipid Res, vol.52, pp.1073-83, 2011.

E. G. Bligh and W. J. Dyer, A rapid method of total lipid extraction and purification, Can J Biochem Physiol, vol.37, issue.8, pp.911-918, 1959.
DOI : 10.1139/y59-099

J. J. Repa, Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta, Genes Dev, vol.14, pp.2819-2849, 2000.
DOI : 10.1101/gad.844900

URL : http://genesdev.cshlp.org/content/14/22/2819.full.pdf

A. C. Calkin and P. Tontonoz, Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR, Nat. Rev. Mol. Cel.l Biol, vol.14, pp.213-237, 2012.

J. R. Schultz, Role of LXRs in control of lipogenesis, Genes Dev, vol.14, pp.2831-2839, 2012.

V. J. Goh and D. L. Silver, The lipid droplet as a potential therapeutic target in NAFLD, Semin Liver Dis, vol.33, issue.4, pp.312-332, 2013.

X. Liu, Personalized characterization of diseases using sample-specific networks, Nucleic Acids Res, vol.44, issue.22, p.164, 2016.
DOI : 10.1093/nar/gkw772

URL : https://academic.oup.com/nar/article-pdf/44/22/e164/8452498/gkw772.pdf

C. S. Choi, Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance, J Biol Chem, vol.31, pp.22678-88, 2007.
DOI : 10.1074/jbc.m704213200

URL : http://www.jbc.org/content/282/31/22678.full.pdf

X. X. Yu, Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice, Hepatology, vol.42, issue.2, pp.362-71, 2005.

P. Chomczynski and N. Sacchi, The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on, Nat Protoc, vol.1, pp.581-586, 2006.

V. T. Samuel and G. I. Shulman, Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases, Cell Metab, vol.27, issue.1, pp.22-41, 2018.

C. Estes, Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease, Hepatology, vol.67, issue.1, pp.123-133, 2018.

F. Chiappini, Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models, Sci Rep, vol.11, issue.6, p.31587, 2016.
DOI : 10.1038/srep31587

URL : http://www.nature.com/articles/srep31587.pdf

Z. Hall, Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease, Hepatology, vol.65, issue.4, pp.1165-1180, 2017.
DOI : 10.1002/hep.28953

URL : https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.28953

P. Puri, A lipidomic analysis of nonalcoholic fatty liver disease, Hepatology, vol.46, issue.4, pp.1081-90, 2007.

P. Puri, The plasma lipidomic signature of nonalcoholic steatohepatitis, Hepatology, vol.50, issue.6, pp.1827-1865, 2009.
DOI : 10.1002/hep.23229

URL : https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.23229

K. Anjani, Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity, J Hepatol, vol.62, issue.4, pp.905-917, 2015.
DOI : 10.1016/j.jhep.2014.11.002

URL : https://hal.archives-ouvertes.fr/hal-01090208

R. Loomba, Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis, J Lipid Res, vol.56, issue.1, pp.185-92, 2015.

S. Ducheix, The liver X receptor: a master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease, Biochem Pharmacol, vol.86, issue.1, pp.96-105, 2013.

K. Chu, Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation, Mol Cell Biol, vol.26, issue.18, pp.6786-98, 2006.

N. Sahini and J. Borlak, Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes, Prog Lipid Res, vol.54, pp.86-112, 2013.

S. Ducheix, A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPAR?, Biochimie, vol.95, pp.556-67, 2013.

S. W. Beaven, Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance, Cell Metab, vol.18, pp.106-123, 2013.

S. Ducheix, Essential fatty acids deficiency promotes lipogenic gene expression and hepatic steatosis through the liver X receptor, J Hepatol, vol.58, issue.5, pp.984-92, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00872314

S. Ducheix, Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling, Plos One, vol.12, issue.7, p.181393, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01606929

E. S. Tien, Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes, Cancer Res, vol.63, pp.5767-80, 2003.

D. Zadravec, Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity, Faseb J, vol.24, pp.4366-77, 2010.